Related Experiment Video
Updated: Jun 10, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Pyrazinamide induced thrombocytopenia
Surya Kant1, Sanjay Kumar Verma, Vaibhav Gupta
1Department of Pulmonary Medicine, Charapati Sahuji Maharaj Medical University, (Erstwhile King Georges Medical University), Lucknow, Uttar Pradesh, India.
Abstract:
Thrombocytopenia is an uncommon but potentially life-threatening complication of certain antitubercular drugs and is characterized by rapid destruction of platelets whenever offending drug is taken by a susceptible person. We report a case of pyrazinamide-induced thrombocytopenia in a patient receiving anti tubercular drugs.
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Toxicity: Dose-Dependent Reactions
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug toxicity: Idiosyncratic Reactions
Pharmacokinetics: Drug–Drug Interactions
Antiviral Nucleoside Inhibitors